Efficacy Of Triphaladi Kwatha And Mustadi Kwatha In The Management Of Dyslipidemia
Not Applicable
Completed
- Conditions
- Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecifiedHealth Condition 2: E00-E89- Endocrine, nutritional and metabolic diseasesHealth Condition 3: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2022/06/043410
- Lead Sponsor
- Government Akhandanand Ayurveda College And Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1)Patient having abnormal one or more elevated lipid level in lipid profile investigation.
Exclusion Criteria
1)Patient having very high level of cholesterol
S. Total cholesterol - > 400 mg/dl
S.Triglyceride - > 400 mg/dl
S. LDL cholesterol - > 400 mg/dl
S. HDL cholesterol - < 10 mg/dl
S. VLDL cholesterol - > 200 mg/d
2)Known cases of Tuberculosis, Carcinoma, IDDM, CCF, HIV, Advanced stage of Diabetes
Mellitus and HTN, Drug Induced Dyslipidemia, CNS disorders and any major liver and
kidney disorder.
3)Patients having past history of MI and Unstable Angina.
4)Associated with any other serious systemic disease or complication, which leads to fatal
conditions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary:-Results will be assesed on the basis of Lipid Profile Reports. <br/ ><br>Timepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method Secondary- Results will be assessed on the basis of improvement in sign and symptoms of Medoroga and AjirnaTimepoint: 8 weeks